跳至主要内容
临床试验/NCT01732666
NCT01732666已完成不适用

Effect of Nefopam on Remifentanil Induced Postoperative Hyperalgesia

Yonsei University1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2012年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
25
试验地点
1
主要终点
Hyperalgesic extent around surgical incision

研究概览

简要总结

Opioids has been reported to cause hyperalgesia. Opioid induced hyperalgesia (OIH) is defined as paradoxically lowering the threshold of pain after the exposure of opioid. Remifentanil is a short acting opioid that is commonly used during anesthesia and surgery. However, OIH was reported to occur after surgery when large amount of remifentanil was administered. On the other hand, nefopam is a centrally acting, non-opioid analgesic. Nefopam has been reported to have analgesic and anti-hyperalgesic effect.

The investigators hypothesized that nefopam administration could prevent OIH or reduce the severity of OIH. Therefore, the objective of the study is to find out the effect of nefopam on remifentanil induced hyperalgesia in patients undergoing laparoscopic abdominal surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients undergoing laparoscopic gastrectomy
  • American Society of Anesthesiologists physical status I or II
  • aged from 20 to 65 years

排除标准

  • Past history of chronic pain
  • Drug or alcohol abuse
  • Psychotic disorder
  • Taking analgesics, anti-epileptics, and anti-depressants.
  • Taking opioids within 24 hrs
  • Renal disease
  • Neuromuscular disease.
  • Moderate to severe cardiovascular disease
  • Pregnant or breast-feeding

研究组 & 干预措施

group L

Placebo Comparator

receives 100 ml of 0.9% saline immediately after anesthesia induction and 0.05µg/kg/min of remifentanil during anesthesia.

干预措施: low dose remifentanil (Drug)

group H

Placebo Comparator

100 ml of 0.9% saline immediately after anesthesia induction and 0.3 µg/kg/min of remifentanil during anesthesia.

干预措施: high dose remifentanil (Drug)

group N

Experimental

20mg of nefopam mixed in 100 ml of 0.9% saline immediately after anesthesia induction and 0.3 µg/kg/min of remifentanil during anesthesia.

干预措施: Nefopam (Drug)

结局指标

主要结局

Hyperalgesic extent around surgical incision

时间窗: Postoperative 24 hr and 48 hr

The distance from the surgical incision to a point where patient does not feel pain when he gets stimuli with von Frey filament No.16 (122g/mm2).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验